Topics

Scottish biotech gains $2.6M to develop next gen SoloMER biologics

04:59 EST 14 Jan 2020 | SmartBrief

Elasmogen, a spin out of Aberdeen University in Scotland, has secured $2.6 million worth of equity that the company will use  -More

Original Article: Scottish biotech gains $2.6M to develop next gen SoloMER biologics

NEXT ARTICLE

More From BioPortfolio on "Scottish biotech gains $2.6M to develop next gen SoloMER biologics"

Quick Search